Enzymus is an independent consulting and advisory services firm dedicated to deliver actionable business insights to early stage and mid-size life science and medical device companies as well as venture capital and private equity firms.

We provide life science and medical device companies with an efficient and cost effective on-demand corporate development, licensing and market intelligence function. Our unique approach of leveraging rigorous research and analytics with broad expertise across therapeutic areas, clinical and commercial disciplines provide executive decision makers with deep insights into value creation and growth opportunities. When we engage with our clients we build capabilities at every level of their organization to achieve long-lasting results.

Our expertise in valuation and market intelligence helps venture capital, private equity and strategic investors with an independent and thorough understanding of the fair value of innovative R&D projects, product portfolios or entire companies.

We are passionate about delivering insightful answers to our client's most critical questions, together with our clients we drive the transformation of their business to achieve significant value in a highly competitive environment.